McKesson Corporation (MCK)
Ameriprise Financial Inc. Has $442.37 Million Stock Holdings in McKesson Corporation $MCK
Ameriprise Financial Inc. lifted its stake in shares of McKesson Corporation (NYSE: MCK) by 33.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 572,569 shares of the company's stock after acquiring an additional 144,869 shares during the quarter. Ameriprise
8 Knots Management LLC Acquires New Holdings in McKesson Corporation $MCK
8 Knots Management LLC bought a new stake in McKesson Corporation (NYSE: MCK) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 17,596 shares of the company's stock, valued at approximately $13,594,000. McKesson comprises approximately 1.5% of 8 Knots
Benchmark Investment Advisors LLC Makes New $468,000 Investment in McKesson Corporation $MCK
Benchmark Investment Advisors LLC purchased a new stake in McKesson Corporation (NYSE: MCK) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 605 shares of the company's stock, valued at approximately $468,000. Other large investors have also added to or reduced their stakes
Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
McKesson Corporation (MCK) Presents at Leerink Global Healthcare Conference 2026 Transcript
McKesson Corporation (MCK) Presents at Leerink Global Healthcare Conference 2026 Transcript
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson Corporation: Strong Q3 Earnings But Upside Exhausted
McKesson Corporation shares are now fairly valued after a 16% price increase, prompting a Hold rating. Strong Q3 results were driven by 11% revenue growth and a 37% surge in the Oncology & Multispeciality segment, aided by M&A. Management raised FY2026 guidance, with EPS now expected at $38.80–39.20 and revenue growth at 12–16%.
Wall Street Analysts Think McKesson (MCK) Is a Good Investment: Is It?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
MCK Q3 Earnings & Sales Top Estimates, 2026 View Up
McKesson beats Q3 EPS and revenue estimates, raises fiscal 2026 guidance, and delivers broad-based growth led by oncology, specialty distribution and technology.
How McKesson Stock Surged 17% In A Day
McKesson (MCK), a prominent pharmaceutical wholesaler, experienced a stock increase of 17% during a high-volume trading session. The driver for this surge was a strong Q3 earnings report that surpassed expectations and, more importantly, a significant rise in the full-year 2026 adjusted EPS forecast.
